Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality(Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds), By Application(Knee, Hip, Ankle and Foot, and Other Application Sites), By Application site(Hyaline Cartilage, Fibrocartilage), By Region - Industry Forecast 2024-2031

Cartilage Repair Market Drivers

• Osteoarthritis has become increasingly common in recent years throughout the world. According to a University of North Carolina study, approximately 1 million knee and hip replacement procedures are performed in the United States each year. The annual cost of osteoarthritis in the United States is $136.8 billion. According to the Arthritis Foundation, degenerative joint diseases such as osteoarthritis will affect more than 130 million people worldwide by 2050. Two of the most common treatments for osteoarthritis are autologous chondrocyte implantation and Scaffolds implants. As a result, as the prevalence of osteoarthritis rises, so will demand for cartilage repair and regeneration products.

Cartilage Repair Market Restraint

Although cartilage repair surgeries provide better and longer-lasting results than total knee replacement surgeries, the cost of these therapies is a major barrier to patient adoption. Knee replacement procedures typically cost around USD 16,000, while cartilage repair procedures typically cost between USD 18,000 and USD 23,000, depending on the region where the procedure is performed. Such high costs undervalue the outcomes of cartilage repair therapies, resulting in a lower preference for these procedures over knee replacement surgeries.